International forum examining cannabis for medical purposes
Medical Cannabis and Cannabinoids is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing and challenging field of the medical use of cannabis and cannabinoids. It seeks to bridge the gap between empirical and evidence-based clinical medicine by covering current basic and applied as well as translational research topics. In addition to original papers, reviews, and mini-reviews, this journal features short communications, case reports, technical notes, letters, and conference proceedings.
About this Journal
The CannX International Medical Cannabis Conference Series
News & Highlights
Now Indexed in PubMed
We are proud to announce that our open access journal Medical Cannabis and Cannabinoids is now indexed in PubMed Central (PMC).
New Tool for Evaluating Potential Drug-Drug Interactions Based on Cannabinoids
CANNabinoid Drug Interaction Review (CANN-DIR®), developed at Penn State College of Medicine, is intended to evaluate for potential drug-drug interactions based on the cannabinoids (THC & CBD) affecting the metabolism of OTHER concomitantly prescribed medications. This tool has been developed for use by healthcare providers, patients, caregivers, and interested community members. Medical Cannabis and Cannabinoids has published a product review on this tool: Drug Interaction Review (CANN-DIR™), utilizing research published in the review Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions, appearing earlier in the journal.